Falsely diagnosed thyrotoxicosis caused by anti-streptavidin antibodies and pre-wash procedures.

IF 1.9 Q3 ENDOCRINOLOGY & METABOLISM
Takuya Ishikawa, Hiroyuki Sakai, Tokutaro Itaya, Suwanai Hirotsugu, Jumpei Shikuma, Takashi Miwa, Ryo Suzuki, Masato Odawara
{"title":"Falsely diagnosed thyrotoxicosis caused by anti-streptavidin antibodies and pre-wash procedures.","authors":"Takuya Ishikawa,&nbsp;Hiroyuki Sakai,&nbsp;Tokutaro Itaya,&nbsp;Suwanai Hirotsugu,&nbsp;Jumpei Shikuma,&nbsp;Takashi Miwa,&nbsp;Ryo Suzuki,&nbsp;Masato Odawara","doi":"10.1186/s13044-021-00108-y","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Anti-streptavidin antibodies are causal determinants of analytical interference during Thyroid function tests, and numerous reports have detailed such interference, with anti-streptavidin antibodies attracting attention.</p><p><strong>Case presentation: </strong>We conducted a straightforward investigation of interference due to anti-streptavidin antibodies, with a case of a 60-year-old Japanese man who consulted our department for inconsistencies between his clinical course and Thyroid function tests. Experiments were conducted using Cobas8000 e602, which employs assay procedures with pre-wash to evaluate FT4 and FT3 levels.</p><p><strong>Conclusions: </strong>To our knowledge, this is the first published report to clearly investigate such interferences using a combination of polyethylene glycol precipitation, heterophilic blocking tube precipitation, streptavidin-coated magnetic particle precipitation, and different instruments with or without pre-wash. Clinicians should consider that interferences caused by anti-streptavidin antibodies could lead to a misdiagnosis of thyrotoxicosis. Moreover, discussions between laboratory specialists, clinicians, and manufacturers are required to identify interferences and avoid unnecessary examinations and inappropriate treatment.</p>","PeriodicalId":39048,"journal":{"name":"Thyroid Research","volume":"14 1","pages":"17"},"PeriodicalIF":1.9000,"publicationDate":"2021-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s13044-021-00108-y","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Thyroid Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s13044-021-00108-y","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 1

Abstract

Background: Anti-streptavidin antibodies are causal determinants of analytical interference during Thyroid function tests, and numerous reports have detailed such interference, with anti-streptavidin antibodies attracting attention.

Case presentation: We conducted a straightforward investigation of interference due to anti-streptavidin antibodies, with a case of a 60-year-old Japanese man who consulted our department for inconsistencies between his clinical course and Thyroid function tests. Experiments were conducted using Cobas8000 e602, which employs assay procedures with pre-wash to evaluate FT4 and FT3 levels.

Conclusions: To our knowledge, this is the first published report to clearly investigate such interferences using a combination of polyethylene glycol precipitation, heterophilic blocking tube precipitation, streptavidin-coated magnetic particle precipitation, and different instruments with or without pre-wash. Clinicians should consider that interferences caused by anti-streptavidin antibodies could lead to a misdiagnosis of thyrotoxicosis. Moreover, discussions between laboratory specialists, clinicians, and manufacturers are required to identify interferences and avoid unnecessary examinations and inappropriate treatment.

由抗链霉亲和素抗体和预洗程序引起的误诊甲状腺毒症。
背景:抗链霉亲和素抗体是甲状腺功能检查中分析干扰的原因决定因素,许多报告详细描述了这种干扰,抗链霉亲和素抗体引起了人们的注意。病例介绍:我们对抗链霉菌亲和素抗体引起的干扰进行了直接的调查,有一个60岁的日本男性病例,他因其临床病程与甲状腺功能检查不一致而咨询我科。实验使用Cobas8000 e602进行,采用预洗的分析程序来评估FT4和FT3水平。结论:据我们所知,这是首次发表的明确研究这种干扰的报告,该报告使用聚乙二醇沉淀法、异亲性阻塞管沉淀法、链霉亲和素包被磁颗粒沉淀法和不同的仪器进行预洗或不预洗。临床医生应考虑抗链霉亲和素抗体引起的干扰可能导致甲状腺毒症的误诊。此外,需要实验室专家、临床医生和制造商之间进行讨论,以确定干扰并避免不必要的检查和不适当的治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Thyroid Research
Thyroid Research Medicine-Endocrinology, Diabetes and Metabolism
CiteScore
3.10
自引率
4.50%
发文量
21
审稿时长
8 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信